Comparative Efficacy of Radiological Modalities in the Diagnosis and Staging of Breast Cancer: A Comprehensive Review

Abstract

The need for multi-level disease care is highlighted by the alarming increase in breast cancer cases. Strict cancer screening programmes or a cancer registry should be the first step in effective management, which should then be followed by effective diagnostic and therapeutic strategies. Breast cancer is extremely variable both in terms of morphology and at the molecular level, necessitating several therapy modalities depending on the molecular subtype. Clinical prognoses for breast cancer patients vary depending on their subtype. The heterogeneity of breast cancer draws attention to the improved that will help with early detection and improved lives of human being. In developed countries, breast cancer affects 12% of women between the ages of 20 and 40, in this population. The risk of long-term side effects from treatment and their impact on quality of life have become increasingly crucial as breast cancer survival rates have significantly increased. Young women make up a small part of breast cancer patients, but they frequently face distinct issues than older women, such as fears about pregnancy, fertility, and contraception. Furthermore, they are worry about the potential negative effects of treatment, the possibility of a recurrence, or the development of a new primary. Additionally, many patients will develop treatment-related side effects, which can be challenging to manage. Emerging disciplines like biopsy and intelligence will help to better understand the complexities of the tumour disease and would help to select the regimen that supports breast disease.  For the curing of breast cancer, a numerous of therapies are including surgery, radiation, chemotherapy, endotherapy, and immunotherapy.

Keywords: Chemotherapy, Surgery, Endotherapy, Clinical prognoses, Immunotherapy.